thegreekdog wrote:PLAYER57832 wrote:No, keeping your blood sugar levels stable are key. For the early stages of Type II, careful diet and excercise management can help, but eventually, most people need insuline. You also have to get regular check-ups, have complications in wound healing, etc.
Though not quite directly related, the US subsidies have created a situation where unhealthy foods -- simple carbohydrates (refined cane sugar, wheat, corn) are cheaper than healthier food unless you are able to grow it yourself.
Okay, so basically what you and snorri are saying is that people in the US that have type II diabetes aren't getting insulin? And then they are, at some later point, expiring because of complications from diabetes?
No, it involves far more than just not getting insulin. It involves not getting the overall care they need before they need insulin (more than just diet and excercise regimes, though those are key).
Also, understand, this is just an example. Diabetes is easy for me to discuss becuase I have family members and close friends who have it. I will use one as an example. He was diagnosed a few years ago. He actually had it a while before being diagnosed, but the doctor he saw did not find it. (I point this out because a lot of the discussion here has been along the lines of "socialized doctors are bad/profit doctors good") He did not get diet counseling. He lives with his mom, who cooks for him. She did not get counseling. I was rather shocked to see her add grape jelly to a dish
while declaring that her son does not eat sugar. Okay, this is not your average american family, but it is also not that far out of norm here. He has had serious trouble regulating his diet. I, a couple of other people I quietly enlisted have tried to gently educate them, but .. this is an older lady set in her ways (why I enlisted help, instead of saying much on my own).
thegreekdog wrote:[What do either of these things have to do with technological advancements? The answer is nothing.
Not true. First, diabetes is just an example, one I know a bit about (and apparently Snorri also). But let's look at what has happened in the past few years. New meters and so forth are coming out. You no longer have to prick your finger, for example. I don't actually know who designed them, but let's say it was fully private. A few years ago, they came out with insulin pumps. These are particularly good for kids and others who have a hard time regulating their blood sugar (just to clarify, Type II means your body does not produce correct amounts of insulin, Type I is when you produce NO insulin -- also sometimes called "juvenile diabetes", though that term is sort of a misnomer). A lot of the research for those was government funded, though again, I don't know the exact mix. (even getting that information is hard because while much of the government funding is public -- though hard to get at sometimes, once it is turned over to private companies it becomes "proprietary" and more often than not the lines get very, very blurry).
You can add into this mix some genetic research. Curing diabetes, understanding it was one of the earliest points of research into gene recombination and splicing. Absolutely, that is mostly government funded and directed.
Now I don't have the time right now to really track all this down. Also, for this level of discussion, I am not sure it really is necessary.
thegreekdog wrote:[On the general technological point, I'm not saying that the treatment of disease or medical breakthroughs are necessarily due to private healthcare systems. What I am saying is I have seen no evidence that the technological breakthroughs of England (whether public or private) are more impressive than the technological breakthroughs in the United States (whether public or private). In the Philadelphia area (both in Pennsylvania and New Jersey) we have some of the more technologically innovative pharmaceutical companies. Some of these companies are European-organized companies with operations in the United States. These operations consist, generally, of technological research. In other words, the technology is researched here and the resultant treatments are produced out of the country. I believe this is done for tax-motivated reasons, but I'm not entirely sure. And these companies are not creating the next Viagra. I can't go into details for privacy reasons, but some of these companies treat actual diseases.
Now you are mixing apples and oranges. The US absolutely has made more medical advances than England, but if you consider how much larger our country is, that is no real surprise. Also, what happens is that when you have a center for advanced research, doctors tend to travel there, rather than starting up new operations.
One point you rather side-stepped is how much of that research is government funded or, how much originated with government funding. For example, Taxol was initially found by government scientists on government land. I myself was among those paid to pay attention to Yew trees (though in my case it was just a minor point -- "while you are out working, look for this tree"), some government workers worked fulltime for a while tracking them down. Then, at some point all the was handed over the pharmaceautical company who actually took the drug to market. No doubt they did some refining. They absolutely conducted tests, but also almost certainly with government oversight.
One thing I did not realize myself until very recently is just how much research is funded by government sources and not private companies at all. Yet, it is the private companies and not taxpayers who get the profits.
It is absolutely possible to balance the two -- profit and public interest. For example, I would have all patents arising from government research issued to the taxpayers (permanently), but then offered to companies for a low royalty rate (either a percentage of profit or a set percent -- I leave the details up to economists). In regards to "orphan" drugs.. drugs that are developed, but the companies don't consider profitable enough to produce, I would perhaps do something of the reverse. Either have the taxpayers buy the patents outrightat a set, low but reasonable rate if a company declines to market a drug for a certain time (or just gives it up) OR offer the company a set, low royalty rate. In some cases, those drugs might need private support to be produced. In other cases, the government might need to do more. The bottom line, though is that the drug patents would not be tying up medication. Any limits would be from other causes.